C11-Erlotinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C11-Erlotinib, covering 2012-10-30 to 2012-10-30. Get the full timeline:
Most recent: Clinical Trial Update: C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR).